NEW YORK (AP) — NEW YORK (AP) — Immunic, Inc. (IMUX) on Wednesday reported a loss of $32.6 million in its first quarter.
On a per-share basis, the New York-based company said it had a loss of $1.08.
The results fell short of Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 71 cents per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IMUX at https://www.zacks.com/ap/IMUX
/Quantum%20Computing/Image%20by%20Funtap%20via%20Shutterstock.jpg)
/A%20Palantir%20sign%20displayed%20on%20an%20office%20building%20by%20Poetra_RH%20via%20Shutterstock.jpg)
/Lululemon%20Athletica%20inc_%20phone%20and%20website%20by-%20T_Schneider%20via%20Shutterstock.jpg)